India bans 328 drugs in setback for pharma firms
By Reuters
September 14, 2018
NEW DELHI: The Indian government has banned 328 combination drugs in a blow to both domestic and foreign pharmaceutical firms, but the ban has been cheered by health activists worried about growing antibiotic resistance due to the misuse of medicines.
The Indian government had in 2016 banned about 350 such drugs, referred to as fixed-dose combinations (FDCs), but the industry mounted various legal challenges that prompted the Supreme Court to call for a review by an advisory board.
The health ministry on Wednesday said the board had found there was "no therapeutic justification for the ingredients contained in 328 FDCs and that these FDCs may involve risk to human beings".
-
Prince William Warned His Future Reign Will Be Affected By Andrew Scandal -
Amy Madigan Reflects On Husband Ed Harris' Support After Oscar Nomination -
Is Studying Medicine Useless? Elon Musk’s Claim That AI Will Outperform Surgeons Sparks Debate -
Margot Robbie Gushes Over 'Wuthering Heights' Director: 'I'd Follow Her Anywhere' -
'The Muppet Show' Star Miss Piggy Gives Fans THIS Advice -
Sarah Ferguson Concerned For Princess Eugenie, Beatrice Amid Epstein Scandal -
Uber Enters Seven New European Markets In Major Food-delivery Expansion -
Hollywood Fights Back Against Super-realistic AI Video Tool -
Pentagon Threatens To Cut Ties With Anthropic Over AI Safeguards Dispute -
Meghan Markle's Father Shares Fresh Health Update -
Samsung Galaxy Unpacked 2026: What To Expect On February 25 -
Travis Kelce Takes Hilarious Jab At Taylor Swift In Valentine’s Day Post -
NASA Confirms Arrival Of SpaceX Crew-12 Astronauts At The International Space Station -
Can AI Bully Humans? Bot Publicly Criticises Engineer After Code Rejection -
Search For Savannah Guthrie’s Abducted Mom Enters Unthinkable Phase -
Imagine Dragons Star, Dan Reynolds Recalls 'frustrating' Diagnosis